GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Mar 31, 2025

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-25-000042General Corporate
Debt relative to revenue35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

368.40% · OPTIONAL · VALID

Capex intensity100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

5.45% · OPTIONAL · VALID

Operating cash generation20thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-0.34% · OPTIONAL · VALID

Revenue growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

-1.00% · CORE · VALID

Inventory pressure60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

133.44% · OPTIONAL · VALID

Gross margin75thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

57.33% · CORE · VALID

R&D intensity65thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.88% · OPTIONAL · VALID

SBC intensity50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.26% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
97.34%
Current
368.40%
Delta
271.06%
Capex Intensity Increased
Previous
3.31%
Current
5.45%
Delta
2.14%
Cash Generation Decreased
Previous
12.19%
Current
-0.34%
Delta
-12.52%
Growth Decreased
Previous
0.50%
Current
-1.00%
Delta
-1.49%
Inventory Pressure Increased
Previous
35.46%
Current
133.44%
Delta
97.99%
Margin Increased
Previous
54.88%
Current
57.33%
Delta
2.46%
R And D Intensity Increased
Previous
7.75%
Current
7.88%
Delta
0.13%
Sbc Intensity Increased
Previous
1.24%
Current
1.26%
Delta
0.02%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_DECREASED →Transitioned To · ELAN GROWTH_DECREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN MARGIN_INCREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.